Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha
about
Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologiesChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageThe role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study.Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers.Evidence of Active Pro-Fibrotic Response in Blood of Patients with CirrhosisTenascins in fibrotic disorders-from bench to bedsideAn independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa-2b combination therapy for chronic hepatitis C.Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.
P2860
Q26752723-D1FC7300-C519-4701-B2EB-15934AA2B8DAQ26773289-5530B595-F41D-42B8-B1AA-DD40CA83807EQ33999294-1D20C924-AAAB-4B92-A0C0-6374EB63B480Q34224706-B71DCD63-769D-449B-819C-CC6FC98334EEQ35193412-E1A8BA1F-4B53-4B4B-8274-7DAA1DA80E2BQ35759086-03344DC1-FA04-41BF-B7C9-E1CE5F847453Q38385217-5F1096C4-D4BB-487F-A2F2-F03F1360401BQ42984780-01DA1D9E-BA56-4999-951F-EE82ED9E848FQ51279076-75B5C7B9-9952-4CDC-96D4-021A170221BB
P2860
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Matrix-derived serum markers i ...... treated with interferon alpha
@ast
Matrix-derived serum markers i ...... treated with interferon alpha
@en
type
label
Matrix-derived serum markers i ...... treated with interferon alpha
@ast
Matrix-derived serum markers i ...... treated with interferon alpha
@en
prefLabel
Matrix-derived serum markers i ...... treated with interferon alpha
@ast
Matrix-derived serum markers i ...... treated with interferon alpha
@en
P2093
P2860
P356
P1476
Matrix-derived serum markers i ...... treated with interferon alpha
@en
P2093
Dariusz-Marek Lebensztejn
Detlef Schuppan
Michael Voelker
P2860
P304
P356
10.3748/WJG.V12.I21.3338
P407
P577
2006-06-01T00:00:00Z